RadNet, Inc. (RDNT) Stock

HealthcareDiagnostics & Research Website

3 of the hedge funds AlphaScala tracks reported RDNT in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Point72's at $30.37M.

Which hedge funds own RDNT?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Point72
Steve Cohen
492K$30.37M-42%
Millennium Management
Israel Englander
466K$28.71M+900%
Soros Fund Management
George Soros (founder)
117K$7.19M-73%

13F holdings as of Jun 30, 2026

Explore all tracked funds →

RDNT price chart

Powered by TradingView

What does RadNet, Inc. do?

RadNet Inc. is a national provider of freestanding, fixed-site outpatient diagnostic imaging services across the United States. It operates through two primary segments: the Imaging Center segment, which delivers essential diagnostic procedures including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy; and the Digital Health segment, which develops and deploys AI-powered clinical applications to enhance medical image interpretation, focusing on brain, breast, prostate, and pulmonary diagnostics via its DeepHealth division. RadNet Inc. maintains a network of owned and operated imaging centers in key markets such as Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas, supporting physicians in disease diagnosis and treatment while advancing proactive healthcare through AI integration for improved accuracy and workflow efficiency. Founded in 1981 and headquartered in Los Angeles, California, RadNet Inc. plays a vital role in the diagnostics and research sector of healthcare.

CEO
Dr. Howard G. Berger M.D.
Employees
8,844
Ask about RDNTAI research agent